Nu Skin Enterprises' (NUS) Hold (C) Rating Reaffirmed at Weiss Ratings

Key Points

• Nu Skin Enterprises' stock received a "hold (c)" rating from Weiss Ratings, indicating a neutral stance from analysts.
• The company reported a net margin of 6.20% and earnings per share of $0.43 for the last quarter, which surpassed expectations.
• Recent insider trading saw a 30.47% decrease in Director Daniel W. Campbell's position after selling 23,391 shares of the company's stock.

Nu Skin Enterprises (NYSE:NUS - Get Free Report)'s stock had its "hold (c)" rating restated by analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Several other analysts have also recently weighed in on NUS. Wall Street Zen cut shares of Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a report on Saturday, October 4th. Zacks Research upgraded shares of Nu Skin Enterprises to a "hold" rating in a research report on Tuesday, August 12th. Four research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $6.88.

Nu Skin Enterprises Stock Down 1.6%

Shares of NUS traded down $0.19 during mid-day trading on Wednesday, hitting $11.08. 16,701 shares of the company's stock were exchanged, compared to its average volume of 644,728. The company has a market cap of $548.19 million, a price-to-earnings ratio of 5.51 and a beta of 0.97. Nu Skin Enterprises has a fifty-two week low of $5.32 and a fifty-two week high of $14.62. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.38 and a current ratio of 2.01. The stock's 50-day moving average is $11.35 and its 200-day moving average is $8.78.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.18. The business had revenue of $386.14 million for the quarter, compared to analysts' expectations of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. On average, sell-side analysts anticipate that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.

Insider Transactions at Nu Skin Enterprises

In related news, Director Daniel W. Campbell sold 23,391 shares of Nu Skin Enterprises stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the sale, the director owned 53,375 shares in the company, valued at approximately $645,837.50. This trade represents a 30.47% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Chayce David Clark sold 20,000 shares of Nu Skin Enterprises stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total value of $239,400.00. Following the completion of the sale, the executive vice president owned 233,140 shares of the company's stock, valued at $2,790,685.80. This trade represents a 7.90% decrease in their position. The disclosure for this sale can be found here. Insiders sold 58,926 shares of company stock valued at $711,364 in the last 90 days. 2.00% of the stock is currently owned by insiders.

Institutional Trading of Nu Skin Enterprises

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its holdings in Nu Skin Enterprises by 102.0% in the 1st quarter. GAMMA Investing LLC now owns 3,498 shares of the company's stock valued at $25,000 after buying an additional 1,766 shares during the period. Atlantic Union Bankshares Corp purchased a new stake in shares of Nu Skin Enterprises during the 2nd quarter worth about $25,000. New York State Teachers Retirement System purchased a new stake in shares of Nu Skin Enterprises during the 1st quarter worth about $33,000. Tower Research Capital LLC TRC grew its holdings in shares of Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company's stock worth $40,000 after purchasing an additional 2,614 shares during the period. Finally, Harbor Capital Advisors Inc. grew its holdings in shares of Nu Skin Enterprises by 2,542.6% during the 1st quarter. Harbor Capital Advisors Inc. now owns 9,117 shares of the company's stock worth $66,000 after purchasing an additional 8,772 shares during the period. Hedge funds and other institutional investors own 82.84% of the company's stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.